Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors

A technology of receptors and ligands, applied in the medical field, can solve problems such as neuroblastoma not displayed

Pending Publication Date: 2019-07-30
恩科格林医疗股份公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It did not show any evidence in the treatment of neuroblastoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors
  • Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors
  • Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0072] definition

[0073] In the description of the present invention, the terms shall be understood to have the following meanings unless otherwise specified.

[0074] "FSHR" refers to the human follicle-stimulating hormone (FSH) receptor; this hormone includes two subunits, alpha and beta.

[0075] "FSH beta" refers to the single beta subunit of human follicle stimulating hormone (FSH); this subunit is characterized by a sequence corresponding to SEQ.ID.no.1.

[0076] "ABRβ" refers to the β subunit of human follicle stimulating hormone (FSH) obtained using a biotechnology platform according to the present invention.

[0077] "ABRβ1" refers to the specific β subunit of human follicle-stimulating hormone (FSH) obtained according to the present invention using a biotechnology platform produced in Nicotiana benthamiana plant cells; this subunit is characterized by Sequence corresponding to SEQ.ID.no.2.

[0078] In general, the FSHβ, ABRβ, and ABRβ1 subunits can be referred t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sizeaaaaaaaaaa
Login to View More

Abstract

The present invention relates to ligands of the follicle stimulating hormone (FSH) receptor for use in the diagnosis and treatment of tumors.

Description

technical field [0001] The invention is applied in the field of medicine, especially in the diagnosis and treatment of tumors. Background technique [0002] Follicle-stimulating hormone (FSH) is a glycoprotein belonging to the class of glycoprotein hormones (GPH), which includes proteins characterized by a high degree of structural similarity, such as thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and chorion-stimulating hormone Gonadal hormones (CG). [0003] FSH is synthesized in the anterior pituitary and released into the bloodstream as a result of gonadotropin releasing hormone (GnRH) stimulation. [0004] FSH plays a key role in reproductive physiology, including the induction of follicle maturation in females and the stimulation of Sertoli cells to promote spermatogenesis in males (Simoni et al. 1997). [0005] Recombinant FSH preparations, such as and or preparations extracted from urine, such as It is routinely used in clinical practice to trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/24A61P35/00C07K14/59
CPCA61K38/24C07K14/59A61P35/00A61P43/00A61K47/64A01H4/001C12N5/0025C12N15/8257G01N33/6893G01N33/74A61K2800/00
Inventor 安德里亚·卡尔皮法比奥·马塞特伦佐·达尔·蒙特
Owner 恩科格林医疗股份公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com